
AKT Inhibition in Prostate Cancer — Proceedings from a Session Held Adjunct to the 2026 ASCO Genitourinary Cancers Symposium
Oncology Today with Dr Neil Love
00:00
Early Clinical Signals with AKT Inhibitors
Karim Fizazi reviews phase 2 results showing benefit of AKT inhibitors with ARPIs in PTEN-deficient patients.
Play episode from 35:24
Transcript


